Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 14.65
Day High 16.64
Open:15.85
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Aphria Inc is licensed to produce and sell medical marijuana, including dried cannabis and cannabis oil, as a Licensed Producer under the provisions of the ACMPR.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Industrial Hemp Floodgates Open as CBD Demand Grows
PR Newswire - Tue Nov 6, 7:30AM CST
PR Newswire - CMTX
Tue Nov 6, 7:30AM CST
CannabisNewsWire Editorial Coverage
Aphria Announces Promotion of Jakob Ripshtein to President
- CNW Group - Fri Nov 2, 1:34PM CDT
CNW Group - CMTX
Fri Nov 2, 1:34PM CDT
Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) announced the promotion of Jakob Ripshtein to President of the Company, effective today. As President, Ripshtein will continue to report to the Chief Executive Officer and have responsibility for the Company's operating units worldwide.
Aphria's Australian-Based Partner Althea Granted Manufacture Licence
- CNW Group - Thu Nov 1, 10:43PM CDT
CNW Group - CMTX
Thu Nov 1, 10:43PM CDT
Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 12.37 +22.47% increase
on 10/30/18
Period Open:17.76
Price movement based on the high, low and last over the given period.
20.96 -27.72% decrease
on 10/16/18
-2.61 (-14.70%) decrease
since 10/01/18
3-Month 8.62 +75.75% increase
on 08/14/18
Period Open:10.57
Price movement based on the high, low and last over the given period.
22.00 -31.14% decrease
on 09/12/18
+4.58 (+43.33%) increase
since 08/01/18
52-Week 7.51 +101.73% increase
on 11/02/17
Period Open:7.80
Price movement based on the high, low and last over the given period.
24.75 -38.79% decrease
on 01/09/18
+7.35 (+94.23%) increase
since 11/01/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement